Bajaj Healthcare Gets CDSCO nod for Phase III clinical trials...
Mumbai: Bajaj Healthcare Ltd. has received the Central Drugs Standard Control Organisation (CDSCO)’s Subject Expert Committee’s (SEC) nod to conduct the Phase III clinical trials for its Suvorexant tablets, a...
